GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention

M.I. Furman, L.A. Krueger, Matthew Linden, M.L. Fox, S.P. Ball, M.R. Barnard, A.L. Frelinger Iii, A.D. Michelson

Research output: Contribution to journalArticlepeer-review

54 Citations (Scopus)
Original languageEnglish
Pages (from-to)312-320
JournalJournal of Thrombosis and Haemostasis
Volume3
Publication statusPublished - 2005

Cite this